CAPN2 and colorectal carcinoma: Indeed, calpains are involved in the cytotoxic effects of genistein and trastuzumab in breast cancer, and of cisplatin in melanoma and ovarian cancer [13–15], while calpain 2 is implicated in the resistance of CRC cells to irinotecan [16].